48 related articles for article (PubMed ID: 33870816)
1. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.
Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
Curr Eye Res; 2021 Oct; 46(10):1551-1558. PubMed ID: 33870816
[No Abstract] [Full Text] [Related]
2. CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo.
Dan H; Lei X; Huang X; Ma N; Xing Y; Shen Y
Microvasc Res; 2021 Jul; 136():104146. PubMed ID: 33610563
[TBL] [Abstract][Full Text] [Related]
3. H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.
Sun Y; Su L; Wang Z; Xu Y; Xu X
BMC Cell Biol; 2013 Feb; 14():8. PubMed ID: 23433118
[TBL] [Abstract][Full Text] [Related]
4. The tumour neovasculature-homing dimeric peptide GX1 demonstrates antiangiogenic activity in the retinal neovasculature.
Luo Y; Yin J; Fang R; Liu J; Wang L; Zhang H; Zhang M; Lei Z; Liang S; Cui W; Zhang Z; Wu K; Hui X
Eur J Pharmacol; 2021 Dec; 912():174574. PubMed ID: 34662566
[TBL] [Abstract][Full Text] [Related]
5. P18 peptide, a functional fragment of pigment epithelial-derived factor, inhibits angiogenesis in hepatocellular carcinoma via modulating VEGF/VEGFR2 signalling pathway.
Wang X; Xiu P; Wang F; Zhong J; Wei H; Xu Z; Liu F; Li J
Oncol Rep; 2017 Aug; 38(2):755-766. PubMed ID: 28627623
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal: Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1.
Cai J; Jiang WG; Grant MB; Boulton M
J Biol Chem; 2006 Feb; 281(6):3604-13. PubMed ID: 16339148
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization.
Raisler BJ; Berns KI; Grant MB; Beliaev D; Hauswirth WW
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8909-14. PubMed ID: 12072560
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the anti-angiogenic effect of the Korean medicinal formula "Sa-mi-yeon-geon-tang" in vitro and in ovo.
Yi JM; Bang OS; Kim NS
BMC Complement Altern Med; 2015 Mar; 15():42. PubMed ID: 25887757
[TBL] [Abstract][Full Text] [Related]
9. RhoA/ROCK Signaling Is Involved in Pathological Retinal Neovascularization.
Tang F; Huang K; Peng B; Deng W; Su N; Xu F; Zhang M; Zhong H
J Vasc Res; 2023; 60(4):183-192. PubMed ID: 37660689
[TBL] [Abstract][Full Text] [Related]
10. Decreasing mitochondrial fission ameliorates HIF-1α-dependent pathological retinal angiogenesis.
Huang SQ; Cao KX; Wang CL; Chen PL; Chen YX; Zhang YT; Yu SH; Bai ZX; Guo S; Liao MX; Li QW; Zhang GQ; He J; Xu YM
Acta Pharmacol Sin; 2024 Jul; 45(7):1438-1450. PubMed ID: 38565961
[TBL] [Abstract][Full Text] [Related]
11. Suppression of retinal neovascularization by intravitreal injection of cryptotanshinone.
Yu Y; Qin X; Chen X; Nie H; Li J; Yao J
Biochem Biophys Res Commun; 2024 Aug; 720():150065. PubMed ID: 38749188
[TBL] [Abstract][Full Text] [Related]
12. ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis.
Sui A; Zhong Y; Demetriades AM; Shen J; Su T; Yao Y; Gao Y; Zhu Y; Shen X; Xie B
Med Sci Monit; 2018 Aug; 24():5860-5873. PubMed ID: 30133427
[TBL] [Abstract][Full Text] [Related]
13. The effects of nepafenac and amfenac on retinal angiogenesis.
Yanni SE; Clark ML; Yang R; Bingaman DP; Penn JS
Brain Res Bull; 2010 Feb; 81(2-3):310-9. PubMed ID: 19897019
[TBL] [Abstract][Full Text] [Related]
14. Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF.
Furumai R; Uchida K; Komi Y; Yoneyama M; Ishigami K; Watanabe H; Kojima S; Yoshida M
Cancer Sci; 2010 Nov; 101(11):2483-9. PubMed ID: 20726856
[TBL] [Abstract][Full Text] [Related]
15. Dual anti-angiogenic and anti-inflammatory action of tRNA-Cys-5-0007 in ocular vascular disease.
Ma Y; Zhang Y; Zhang HY; Zhao Y; Li XM; Jiang YF; Yao MD; Jiang Q; Yan B
J Transl Med; 2024 Jun; 22(1):562. PubMed ID: 38867291
[TBL] [Abstract][Full Text] [Related]
16. Bioresponsive cancer-targeted polysaccharide nanosystem to inhibit angiogenesis.
Yang F; Fang X; Jiang W; Chen T
Int J Nanomedicine; 2017; 12():7419-7431. PubMed ID: 29066892
[TBL] [Abstract][Full Text] [Related]
17. A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization.
Cano Mdel V; Karagiannis ED; Soliman M; Bakir B; Zhuang W; Popel AS; Gehlbach PL
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3840-5. PubMed ID: 19279315
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic activity of the lipophilic antimicrobial peptides from an endophytic bacterial strain isolated from red pepper leaf.
Jung HJ; Kim Y; Lee HB; Kwon HJ
Mol Cells; 2015 Mar; 38(3):273-8. PubMed ID: 25556370
[TBL] [Abstract][Full Text] [Related]
19. Posterior eye delivery of angiogenesis-inhibiting RNA nanoparticles via subconjunctival injection.
Zhong C; Shi Z; Binzel DW; Jin K; Li X; Guo P; Li SK
Int J Pharm; 2024 May; 657():124151. PubMed ID: 38657717
[TBL] [Abstract][Full Text] [Related]
20. Enhanced therapeutic effect of PEDF-loaded mesenchymal stem cell-derived small extracellular vesicles against oxygen-induced retinopathy through increased stability and penetrability of PEDF.
Fan R; Su L; Zhang H; Jiang Y; Yu Z; Zhang X; Li X
J Nanobiotechnology; 2023 Sep; 21(1):327. PubMed ID: 37684667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
